FDA Approvals: Adderall XR for Adults, Topamax for Migraines, and Others

"The U.S. Food and Drug Administration (FDA) has approved mixed salts of a single-entity amphetamine for use in adults with attention deficit hyperactivity disorder, topiramate for migraine prophylaxis in adults, a new algorithm to improve distribution of radiation therapy in heterogenous body areas, and two drugs to treat internal contamination from radioactive elements."